In vitro screening of compounds from the Food and Drug Administration-approved library identifies anti-Babesia gibsoni activity of idarubicin hydrochloride and vorinostat

Babesia gibsoni Infection in Dogs—A European Perspective

(2022) Oliwier Teodorowski et al.   Animals

DNA topoisomerases in the unicellular protozoan parasites: Unwinding the mystery

(2022) Swati Lamba et al.   BIOCHEMICAL PHARMACOLOGY

In vitro screening of novel anti-Babesia gibsoni drugs from natural products

(2021) Shengwei Ji et al.   PARASITOLOGY INTERNATIONAL

Drug screening of food and drug administration-approved compounds against Babesia bovis in vitro

(2020) Yongchang Li et al.   EXPERIMENTAL PARASITOLOGY

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study

(2020) Seth E Karol et al.   LANCET ONCOLOGY

Closing the empty anti-Babesia gibsoni drug pipeline in vitro using fluorescence-based high throughput screening assay

(2020) Mohamed Abdo Rizk et al.   PARASITOLOGY INTERNATIONAL

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

(2020) Fatemeh Heidary et al.   JOURNAL OF ANTIBIOTICS

Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial

(2019) Boris Guiu et al.   RADIOLOGY

Molecular evidence for the transovarial passage of Babesia gibsoni in Haemaphysalis hystricis (Acari: Ixodidae) ticks from Taiwan: a novel vector for canine babesiosis

(2018) Frans Jongejan et al.   Parasites & Vectors

Antiprotozoal treatment of canine babesiosis

(2018) Gad Baneth   VETERINARY PARASITOLOGY

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

(2018) Youn H Kim et al.   LANCET ONCOLOGY

Effect of clinically approved HDAC inhibitors on Plasmodium , Leishmania and Schistosoma parasite growth

(2017) Ming Jang Chua et al.   International Journal for Parasitology-Drugs and Drug Resistance

Clofazimine Inhibits the Growth of Babesia and Theileria ParasitesIn VitroandIn Vivo

(2016) Bumduuren Tuvshintulga et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A review of canine babesiosis: the European perspective

(2016) Laia Solano-Gallego et al.   Parasites & Vectors

Histone deacetylases as targets for treatment of multiple diseases

(2013) Jinhua Tang et al.   CLINICAL SCIENCE

Detection ofBabesia gibsoniand the canine smallBabesia‘Spanish isolate’ in blood samples obtained from dogs confiscated from dogfighting operations

(2009) Todd J. Yeagley et al.   JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION

Possible Emergence of Drug-Resistant Variants ofBabesia gibsoniin Clinical Cases Treated with Atovaquone and Azithromycin

(2009) M. Sakuma et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Cloning, Expression, and Characterization of Babesia gibsoni Dihydrofolate Reductase-Thymidylate Synthase: Inhibitory Effect of Antifolates on Its Catalytic Activity and Parasite Proliferation

(2008) G. O. Aboge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY